Social Media Ideas for Cronus Pharma

Cronus Pharma launches first FDA-approved injection for veterinary use to control postoperative pain in dogs and cats

Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing cost-effective animal health products, announced Aug. 26 the U.S. launch of Robenacoxib Injection, the...

Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript

Pharmacosmos Therapeutics

Pharmacosmos Therapeutics Anonymous (not verified) Fri, 10/16/2026 - 10:12 field_thread_url https://cafepharma.com/boards/threads/pharmacosmos-therapeutics...

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

Rhythm Pharma

Rhythm Pharma Anonymous (not verified) Tue, 10/06/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/rhythm-pharma.674576/...

Cadence Neuroscience Appoints Medtech Executive Chris Cronin as CEO to Lead Clinical Execution and Platform Growth

Veteran medtech executive brings leadership experience across neuromodulation, clinical-stage company building, and commercialization; Founder Kent Leyde to lead technology and pro...

Rhythm Pharma

Rhythm Pharma Anonymous (not verified) Mon, 09/28/2026 - 01:03 field_thread_url https://cafepharma.com/boards/threads/rhythm-pharma.674576/...

Curity Pharma Launches Its First Products in the Greek Market

Curity Pharma Launches Its First Products in the Greek Market The Greek pharmaceutical company enters a new phase of growth with the launch of finished medical cannabis products th...

Corvus Pharmaceuticals: Steady As She Goes With Strong Footing In Atopic Dermatitis Treatment

Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA

~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~

Hepion unit receives FDA feedback on gambling disorder drug

Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth a...

Key HighlightsRecord revenue: preliminary nine-month 2026 revenue of approximately $54.3 million, up 19%, with every quarter of 2026 setting a record2026 outlook reaffirmed: full-y...

NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals

Innovative Delivery Technologies Aimed at Enhancing Bioavailability and Expanding Patient Access Beyond Traditional Injections

Cumberland Pharmaceuticals stock tumbles on trial results

<![CDATA[Viatris Acquires Pacira BioSciences for $1.65 Billion ]]>

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health...

Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market

<![CDATA[Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somniver...

Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gros...

Contract manufacturing pipeline surpasses $20 million in implied revenue at wholly owned subsidiary Cana Laboratories, representing over $18 million in implied gross profit across...

Compound Solutions' TeaCrineВ® and DynamineВ® Featured in Roonв„ў's Caffeinated Cool Mint Pouches, the First Buccal Deli...

Roonв„ў pairs TeaCrineВ® and DynamineВ® with caffeine and L-theanine in a nicotine-free cool mint pouch built to optimize the energy experience. CARLSBAD, Calif., Sept. 21, 2026 /P...

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

PRNewswireMumbai (Maharashtra) [India], October 1: Piramal Pharma Solutions ('PPS'), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal...

Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data

Novo’s latest alliance involves injectables given every one to three months. Elsewhere, Nektar won a legal spat with Eli Lilly and the FDA issued two approvals.

Consano Bio Raises More Than $15 Million in Oversubscribed Financing to Advance C-1101 in Chronic Painful Lumbosacral Ra...

Proceeds will fund completion of the Phase 1 trial and continued development of C-1101, a potential first-in-class disease-modifying therapeutic -- Clinical data expected in 1H 202...

Revolution Medicines

Revolution Medicines Anonymous (not verified) Wed, 09/30/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...